This analysis of 2 cohort studies and a mouse model examined the association of clonal hematopoiesis of indeterminate potential with cardiotoxic effects in patients with breast cancer receiving trastuzumab.
JAMA Oncology published a clinical update in Oncology on 02 Apr 2026.
The item focuses on Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxic Effects.
Review the original article for the full source wording and details.